Beatriz Arteta Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2019	Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance.
9/2010	alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beatriz Arteta Research Topics

Disease

16	Neoplasms (Cancer) 03/2022 - 10/2008
16	Neoplasm Metastasis (Metastasis) 03/2022 - 10/2008
9	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 10/2008
3	Adenocarcinoma 01/2019 - 09/2010
2	Carcinoma (Carcinomatosis) 10/2020 - 06/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 09/2010
2	Melanoma (Melanoma, Malignant) 01/2013 - 11/2009
2	Fibrosis (Cirrhosis) 11/2012 - 12/2011
1	Experimental Melanoma 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 06/2021
1	COVID-19 06/2021
1	Colonic Neoplasms (Colon Cancer) 11/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2012
1	Inflammation (Inflammations) 11/2012
1	Neoplasm Micrometastasis 10/2008
1	Sepsis (Septicemia) 08/2008
1	Dyslipidemias (Dyslipidemia) 08/2008

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 12/2017 - 08/2008
4	Messenger RNA (mRNA)IBA 03/2022 - 06/2017
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2021 - 06/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 10/2008
3	CollagenIBA 01/2022 - 11/2012
3	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 11/2019 - 10/2008
2	Discoidin Domain Receptor 2IBA 01/2022 - 12/2011
2	Complement System Proteins (Complement)IBA 01/2019 - 06/2017
2	OcoxinIBA 01/2019 - 06/2017
2	SolutionsIBA 01/2019 - 03/2016
2	IntegrinsIBA 12/2017 - 10/2008
2	LigandsIBA 11/2013 - 01/2013
2	beta-Galactoside alpha-2,3-SialyltransferaseIBA 08/2013 - 09/2010
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013 - 11/2009
2	Mannose ReceptorIBA 01/2013 - 06/2010
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 11/2009
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 06/2010
2	Desipramine (Pertofrane)FDA LinkGeneric 01/2013 - 11/2009
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2013 - 11/2009
1	ResveratrolIBA 03/2022
1	DesminIBA 03/2022
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 03/2022
1	Neuropilin-1IBA 06/2021
1	Celecoxib (Celebrex)FDA Link 05/2021
1	Dinoprostone (PGE2)FDA Link 05/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	Collagen ReceptorsIBA 10/2020
1	Chemotactic FactorsIBA 10/2020
1	Gemcitabine FDA Link 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	ChemokinesIBA 04/2018
1	plerixafor FDA Link 04/2018
1	CXCR4 Receptors (CXCR4 Receptor)IBA 04/2018
1	Chemokine CXCL12IBA 04/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2017
1	Trans-Activators (Trans-Acting Factor)IBA 11/2013
1	SialyltransferasesIBA 08/2013
1	Sialyl Lewis X AntigenIBA 08/2013
1	FucosyltransferasesIBA 08/2013
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2013
1	MitogensIBA 01/2013
1	mannoproteinsIBA 01/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2013
1	Interleukin-18 (Interleukin 18)IBA 01/2013
1	metaperiodate (periodate)IBA 01/2013
1	Mannose (D-Mannose)IBA 01/2013
1	AntigensIBA 11/2012
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2011
1	Fibrillar CollagensIBA 12/2011
1	EnzymesIBA 09/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2010
1	InterferonsIBA 06/2010
1	AntibodiesIBA 06/2010
1	Interleukin-1 (Interleukin 1)IBA 06/2010
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2009
1	Metalloproteases (Metalloproteinases)IBA 11/2009
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2008
1	LipidsIBA 08/2008
1	Apolipoproteins B (ApoB)IBA 08/2008

Therapy/Procedure

4	Therapeutics 06/2017 - 06/2010
1	Drug Therapy (Chemotherapy) 06/2017
1	Subcutaneous Injections 01/2013